National Clinical Guidelines
The Cancer Strategy 2006 recommended that national site-specific multi-disciplinary groups should be convened to develop evidence based guidelines for common cancers.
- Aim to improve the quality of clinical care
- Aim to prevent variation in practice
- Are based on the best research evidence in conjunction with clinical expertise
The National Cancer Control Programme (NCCP) is developing national evidence-based clinical guidelines for the diagnosis, staging and treatment of common cancers, through its "Guideline Development Groups" commencing with:
Evidence into practice - rapid reviews
COVID-19 Guidance is available here
The NCCP have developed a number of guidance documents that are available here and in the HSE COVID-19 Clinical Guidance and Evidence Repository.
Last updated 09th March 2023